C.R. Bard Inc. and Davol Inc. won the first test trial in multidistrict litigation over their hernia mesh devices, as a federal jury rejected a Utah man’s claims challenging the product design and warnings.
The companies, now owned by
Steven Johns said Ventralight ST mesh products used in two hernia repair procedures caused abdominal adhesions that left him with chronic pain.
He alleged that the polypropylene used in ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.